Loading...
•
Dec 31, 2020
Utah Medical Q4 2020 Earnings Report
Financial results for the fourth quarter were reported, confirming a recovery trend from the COVID-19 depression.
Key Takeaways
Utah Medical Products reported its Q4 2020 financial results, showing a recovery from the COVID-19 depression with the best revenue quarter of the year, almost 2% higher than the pre-pandemic Q4 2019. However, net income decreased by 21.7% compared to Q4 2019.
Q4 2020 was UTMD’s best revenue quarter of the year, almost 2% higher than the pre-pandemic 4Q 2019.
Consolidated total worldwide revenues for the 2020 year were 10% lower than in 2019.
Foreign currency revenues in 4Q 2020 were increased by $135 as a result of a weaker USD compared to particularly the EUR and AUD.
UTMD’s December 31, 2020 Balance Sheet remained strong with an absence of debt.
Revenue by Geographic Location
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...